Welcome to our dedicated page for TrueBlue SEC filings (Ticker: TBI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TrueBlue, Inc. filings document the public-company disclosures of a specialized workforce solutions provider whose common stock trades on the New York Stock Exchange under TBI. Its Form 8-K reports cover quarterly results, Regulation FD materials, material agreements, financing arrangements, executive appointments and governance-related communications.
TrueBlue proxy and related filings describe annual meeting matters, board governance, compensation and shareholder voting procedures. Recent filings also document amendments to the company’s credit agreement, stockholder rights arrangements, the expiration and withdrawal from listing of preferred stock purchase rights, and solicitation materials connected to shareholder engagement and board matters.
TrueBlue, Inc. (TBI) furnished an 8-K announcing a press release with financial results for the third quarter ended September 28, 2025 and outlook for the fourth quarter and fiscal year 2025. The company also provided an earnings slide deck and an investor roadshow presentation.
Management will discuss the results on a live conference call at 2:00 p.m. Pacific Time on November 3, 2025. Materials were furnished under Regulation FD. Exhibits include 99.1 (press release), 99.2 (earnings presentation), and 99.3 (investor roadshow).
Boston Partners filed a Schedule 13G reporting beneficial ownership of 1,611,515 shares of TrueBlue, Inc. common stock, representing 5.39% of the class as of 09/30/2025.
The firm reports sole voting power over 1,611,515 shares and sole dispositive power over 1,611,515 shares, with no shared voting or dispositive power. The shares are held for the discretionary accounts of certain clients, and Boston Partners is classified as an investment adviser (IA).
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
The Vanguard Group filed Amendment No. 17 to Schedule 13G for TrueBlue, Inc. (TBI), reporting beneficial ownership of 1,631,027 common shares, representing 5.45% of the class as of September 30, 2025.
The filing shows 0 shares with sole voting power and 186,011 with shared voting power. Vanguard reports 1,435,865 shares with sole dispositive power and 195,162 with shared dispositive power. Vanguard certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Insider sale by TrueBlue CEO/President and Director. The filing shows that Taryn R. Owen, who serves as CEO and President and a director, reported a sale of 1,436 shares of TrueBlue, Inc. (TBI) on 10/03/2025 at a price of $6.06 per share. After this transaction she beneficially owns 411,024 shares.
The Form 4 was signed by an attorney-in-fact on 10/07/2025. The report is a routine Section 16 disclosure showing a non-derivative disposition of common stock; no derivative transactions or additional remarks are reported in Table II or the explanation section.
TrueBlue, Inc. (TBI) insider sale by CEO — The CEO and President, Owen Taryn R, reported a sale of 2,472 shares of common stock on 10/02/2025 at a reported price of $5.62 per share. After the sale, the filing shows 412,460 shares beneficially owned outright. The Form 4 was signed on 10/06/2025 by an attorney-in-fact. No derivative transactions or additional remarks were disclosed in the filing.
TrueBlue, Inc. insider Jason Embick, Senior Vice President and Chief Accounting Officer, reported a sale of 700 shares of Common Stock on 09/03/2025 at a price of $5.72 per share. After the sale he beneficially owns 33,648 shares directly. The Form 4 was signed by an attorney-in-fact on 09/05/2025.
Royce & Associates LP filed Amendment No. 3 to Schedule 13G reporting its ownership in TrueBlue, Inc. (TBI) as of 30 Jun 2025.
- Beneficial ownership: 2,360,082 common shares
- Ownership percentage: 7.90 % of outstanding shares
- Sole voting power: 2,360,082 shares; no shared voting power
- Sole dispositive power: 2,360,082 shares; no shared dispositive power
The filer is classified as an investment adviser (Rule 13d-1(b)(1)(ii)(E)) and certifies the shares were acquired in the ordinary course of business, without intent to influence control of the issuer. Royce & Associates, an indirect majority-owned subsidiary of Franklin Resources, disclaims group status with other Franklin affiliates and any pecuniary interest beyond its clients’ accounts.